한글목차

세계 OTC 약, 의료기기 및 진단 제품 시장 규모는 2024년 2,517억 달러에서 예측 기간 동안 CAGR 7.4%로 추이하고, 2029년에는 3,597억 달러에 달할 것으로 예측되고 있습니다.

OTC 약물 부문은 2024년 1,965억 달러에서 예측 기간 동안 CAGR 6.7%로 추이하고, 2029년에는 2,717억 달러에 이를 것으로 예측됩니다. OTC 기기 및 진단 제품 부문은 2024년 552억 달러에서 CAGR 9.8%로 성장을 지속하여 2029년에는 880억 달러에 달할 것으로 예측됩니다.

이 보고서는 세계 OTC 의약품, 의료기기 및 진단 제품 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각종 구분, 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• OTC 제품 유형
• OTC 약
• 비타민·미네랄 보충제
• OTC 의료기기 및 진단 제품
• OTC약, 의료기기 및 진단 제품의 장단점
• 비용 절감 분석
• PESTLE 분석
• Porter's Five Forces 분석
• 규제 상황

제3장 시장 역학

• 시장 역학
• 시장 성장 촉진요인
• 만성 질환 증가와 노인 인구의 확대
• 건강 의식 향상
• 성장하는 온라인 판매 채널과 원격 의료 플랫폼
• 시장 성장 억제요인
• 대체 수단의 존재
• 시장 기회
• 신흥경제국
• 시장의 과제
• OTC약과 의료기기의 오용과 상호작용
• 데이터 프라이버시 및 보안에 대한 우려

제4장 신기술과 개발

• 신흥기술
• 고급 약물전달
• 고급 웨어러블 센서
• AI
• 임상시험 분석
• 임상시험 분석 : 연구 유형별
• 임상시험 분석 : 상태별
• 임상시험 분석 : 위상별

제5장 시장 세분화 분석

• 세분화의 내역
• 시장 분석 : 제품별
• OTC 약
• 의약품
• 비타민&미네랄 보충제
• OTC 디바이스 및 진단 제품
• 감시 디바이스
• 치료 장치
• 진단 디바이스 및 키트
• 시장 분석 : 용도별
• 호흡기 질환
• 위장 장애
• 정형외과 질환
• 심혈관 질환
• 당뇨병
• 피부질환
• 비만
• 이비인후과 질환
• 수면장애
• 기타
• 지리적 내역
• 시장 분석 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제6장 경쟁 정보

• 시장 분석
• 전략 분석

제7장 OTC약, 의료기기 및 진단 제품에 있어서의 지속가능성 : ESG의 관점

• ESG 소개
• OTC 의약품, 의료기기, 진단에 있어서의 지속가능성:ESG의 관점
• 주요 ESG 문제
• OTC 약, 의료기기, 진단 제품의 ESG 성능 분석
• BCC에 의한 총론

제8장 부록

• 조사 방법
• 출처
• 약어
• 기업 프로파일
• ABBOTT
• BAYER AG
• DSM-FIRMENICH
• HALEON GROUP OF CO.
• KENVUE
• KONINKLIJKE PHILIPS NV
• MASIMO
• NESTLE
• PROCTER & GAMBLE
• SANOFI

영문목차

The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.

The OTC drugs market for OTC drugs, medical devices, and diagnostics is estimated to increase from $196.5 billion in 2024 to reach $271.7 billion by 2029, at a CAGR of 6.7% from 2024 through 2029.

The OTC devices and diagnostics market for OTC drugs, medical devices, and diagnostics is estimated to increase from $55.2 billion in 2024 to reach $88.0 billion by 2029, at a CAGR of 9.8% from 2024 through 2029.

Report Scope:

The current report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics based on products and applications. Based on product, OTC drugs, medical devices, and diagnostics are categorized into OTC drugs (pharmaceutical drugs and vitamin and mineral supplements) and OTC devices and diagnostics (monitoring devices, therapeutic devices, and diagnostic devices and kits). Based on application, the report is segmented into respiratory disorders, orthopedic diseases, gastrointestinal disorders, diabetes, obesity, cardiovascular diseases, ENT disorders, skin disorders, sleep disorders, and other disorders.

Report Includes:

• 36 data tables and 69 additional tables
• An up-to-date overview of the global markets for OTC drugs, medical devices and diagnostics
• Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by product type, application, and geographic region
• Discussion of how the rise in the number of diseases are creating a constant need for OTC drugs, medical devices, and diagnostics for disease management
• A look at the key market drivers and restraints that will shape the market for OTC drugs, medical devices, and diagnostics over the next five years (2024-2029)
• A discussion on ESG challenges and practices in the industry
• Review of patents issued for OTC drugs, medical devices, and diagnostics
• Assessment of the vendor landscape, including the market shares of leading companies, their product portfolios and financial overviews
• Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
• Company profiles of major players within the industry, including Haleon Group of Co., Kenvue, Sanofi, and Bayer AG

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Introduction
• Types of OTC Products
• Pharmaceutical OTC Drugs
• Vitamin and Mineral Supplements
• OTC Medical Devices and Diagnostics
• Advantages and Disadvantages of OTC Drugs, Medical Devices, and Diagnostics
• Cost Savings Analysis
• PESTLE Analysis
• Porter's Five Forces Analysis
• Bargaining Power of Buyers: High
• Bargaining Power of Suppliers: Moderate
• Potential of New Entrants to the Market: Moderate
• Competition in the Industry: High
• Threat of Substitutes: Moderate to High
• Regulatory Landscape
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Growing Prevalence of Chronic Diseases and Expanding Geriatric Populations
• Increasing Health Awareness
• Growing Online Sales Channels and Telehealth Platforms
• Market Restraints
• Presence of Alternative Methods
• Market Opportunities
• Emerging Economies
• Market Challenges
• Misuse and Interactions of OTC Drugs and Medical Devices
• Data Privacy and Security Concerns

Chapter 4 Emerging Technologies and Developments

• Emerging Technologies
• Advanced Drug Delivery
• Advanced Wearable Sensors
• Artificial Intelligence
• Clinical Trials Analysis
• Clinical Trials Analysis by Type of Study
• Clinical Trials Analysis, by Status
• Clinical Trials Analysis, by Phase

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product
• OTC Drugs
• Pharmaceutical Drugs
• Vitamin and Mineral Supplements
• OTC Devices and Diagnostics
• Monitoring Devices
• Therapeutic Devices
• Diagnostic Devices and Kits
• Market Breakdown by Application
• Respiratory Disorders
• Gastrointestinal Disorders
• Orthopedic Diseases
• Cardiovascular Diseases
• Diabetes
• Skin Disorders
• Obesity
• ENT Disorders
• Sleep Disorders
• Other Disorders
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Market Analysis
• Strategic Analysis

Chapter 7 Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective

• Introduction to ESG
• Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective
• Key ESG Issues
• OTC Drug, Medical Device, and Diagnostics ESG Performance Analysis
• Concluding Remarks from BCC

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBOTT
• BAYER AG
• DSM-FIRMENICH
• HALEON GROUP OF CO.
• KENVUE
• KONINKLIJKE PHILIPS N.V.
• MASIMO
• NESTLE
• PROCTER & GAMBLE
• SANOFI